1. No category

brought to you by
Novel Patent-Pending
Solutions
Invented by ophthalmologists
and pharmacists
Patent-pending SSP TechnologyTM
uniquely allows the combination of drugs
Tri-Moxi
Shift the Treatment Paradigm
Triamcinolone acetonide and
moxifloxacin hydrochloride
Tri-Moxi-Vanc
Reduce issues with
patient compliance
Decrease
overall costs
Single intraocular
administration
Triamcinolone acetonide, moxifloxacin
hydrochloride and vancomycin
Lyophilized Mydriatics
PROPRIETARY STERILE INJECTABLE
COMPOUNDED FORMULATIONS†
Dropless Cataract SurgeryTM
Dropless delivery of medications originated for the purpose of fulfilling an unmet
need for ophthalmologists and their patients undergoing cataract surgery.
Place an order today at
www.GoDropless.com/orders
Compounding with an Imprimis Pharmacy
Image courtesy: James Lewis, MD
Delivery Technique
Ophthalmologists currently using our Dropless TherapyTM
compounded formulations believe the optimal location for
the injection would be the vitreous due to the depot effect.
This is achieved by one of two ways: entering through the
zonules (or “transzonularly”) and through pars plana injection.
Learn more and browse through multiple
surgical videos in our educational portal.
At Imprimis Pharmaceuticals, we are committed to delivering high quality formulations that
meet or exceed stringent U.S. Pharmacopeia (USP) guidelines.
The formulations have been optimized for the isotonicity and pH most compatible with the
eye, and their particle size has been homogenized to smoothly dispense in the vitreous upon
injection through a small cannula. Additionally, every batch is tested for sterility and bacterial
endotoxins.
We can provide many other compounded medications to meet your patients’ needs.
Contact an Imprimis pharmacist today at [email protected]
DYNALABS Continuous Quality
Improvement (CQI) // PCAB ACCREDITED
Gain instant access today at
www.GoDropless.com/portal
The GoDropless™ educational campaign is brought to you by San Diego-based Imprimis
Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company dedicated to delivering
high quality, novel, and customizable medicines to physicians and patients at accessible prices.
For more information on Imprimis, visit www.imprimispharma.com
brought to you by
†Compounded by a pharmacist pursuant to a prescription to meet the needs of individual patients. May be customized. Some patients may need drops.
Dropless Therapy, GoDropless, Dropless Cataract Surgery and SSP Technology are trademarks of Imprimis Pharmaceuticals, Inc.
©2015 Imprimis Pharmaceuticals, Inc. All Rights Reserved.
IMPO0055 D 04/15